Scalable Solutions Office: Office-Wide Innovative Solutions Opening for Advanced Research Projects Agency for Health
ARPA-H seeks innovative proposals to scale healthcare solutions, improve access in underserved areas, and advance biomanufacturing through technology, networks, and streamlined processes.
This grant is no longer accepting proposals
Advanced Research Projects Agency for Health has archived this opportunity.
Funder: Advanced Research Projects Agency for Health (ARPA-H)
Due Dates: March 14, 2024 (Original Response Date) | Note: This opportunity is archived and no longer accepting proposals
Funding Amounts: Funding type: Cooperative Agreement; specific award amounts not stated; supports high-risk, high-reward biomedical and health research with typical project durations of 3-5 years.
Summary: Supports innovative, scalable healthcare solutions to improve access and affordability, especially in underserved areas, and advances biomanufacturing technologies through interdisciplinary and collaborative approaches.
Key Information: Proposals must be revolutionary, not incremental; clinical trial stage projects and policy or infrastructure proposals are excluded. Focus areas include scalable technologies, collaborative distribution networks, and biomanufacturing innovations.
Description
The Advanced Research Projects Agency for Health (ARPA-H) Scalable Solutions Office (SSO) seeks innovative solution summaries and proposals that address the challenges of scaling healthcare solutions to improve access, affordability, and equity across diverse geographic and demographic contexts in the United States. The goal is to overcome barriers such as geographic distribution, manufacturing bottlenecks, and data/information challenges to enhance healthcare delivery, especially in underserved and remote areas.
Key focus areas include:
-
Scalable Technologies and Interventions: Developing adaptable, affordable healthcare solutions deployable at scale, including telemedicine, point-of-care diagnostics, modular infrastructure, and pediatric-specific interventions. Emphasis is on reducing health disparities and enabling provider/institutional capability scaling.
-
Collaborative Distribution Networks: Creating methods to standardize and automate complex healthcare procedures, enhance delivery in rural or low-resource settings, enable rapid deployment of critical resources during crises, and scale education and training for healthcare providers and patients.
-
Biomanufacturing Innovations: Innovating manufacturing technologies to reduce costs, shorten production timelines, improve domestic competitiveness, and reduce supply chain risks for biologics, pharmaceuticals, medical devices, and protective equipment. This includes developing scalable biological production, reducing cold chain reliance, and strengthening supply chains.
ARPA-H encourages proposals that are disease-agnostic but also welcomes those addressing specific diseases such as cancer, diabetes, neurological disorders, pediatric and maternal/fetal health, infectious diseases, and cardiovascular disease.
Proposals must be revolutionary and transformative, not incremental or evolutionary. Projects at the clinical trial stage or focused on policy changes, traditional education/training, center formation, or physical infrastructure construction are outside the scope.
